Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder.

[1]  J. McKenney,et al.  Discriminatory Immunohistochemical Staining of Urothelial Carcinoma in Situ and Non-neoplastic Urothelium: An Analysis of Cytokeratin 20, p53, and CD44 Antigens , 2001, The American journal of surgical pathology.

[2]  H. Khaled,et al.  Bladder cancer in Africa: update. , 2001, Seminars in oncology.

[3]  S. Nordling,et al.  Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. , 2001, The American journal of pathology.

[4]  C. Sakakura,et al.  Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[6]  Y. Shyr,et al.  Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. , 2000, The American journal of pathology.

[7]  J. Celis,et al.  Bladder squamous cell carcinoma biomarkers derived from proteomics , 2000, Electrophoresis.

[8]  J. Southgate,et al.  Expression of cytokeratin 20 redefines urothelial papillomas of the bladder , 1999, The Lancet.

[9]  T. Ahlering,et al.  Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. , 1997, The Journal of urology.

[10]  J. Southgate,et al.  Cytokeratin 20 as an objective marker of urothelial dysplasia. , 1996, British journal of urology.

[11]  J. Nesland,et al.  Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours , 1993, Histopathology.

[12]  R. Moll,et al.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. , 1992, The American journal of pathology.

[13]  G. Wedemeyer,et al.  Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells. , 1989, Cancer research.